Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 18/20 | 0.72 |
| ▸ | HDAC3 | O15379 | 14/20 | 0.72 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.72 |
| ▸ | HDAC8 | Q9BY41 | 7/20 | 0.72 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.72 |
| ▸ | NCOR1 | O75376 | 2/20 | 0.72 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.64 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.62 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.53 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23746023 | 0.84 | HDAC1 (1.00) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL5584503 | 0.82 | HDAC1 (0.72) | HDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL22874432 | 0.82 | HDAC1 (0.67) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL23746024 | 0.82 | HDAC1 (0.90) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL20128319 | 0.81 | HDAC1 (0.67) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL13713672 | 0.81 | HDAC1 (0.74) | HDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL23745952 | 0.81 | HDAC1 (0.72) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL11398234 | 0.80 | P4HTM (0.78) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL213540 | 0.78 | HDAC1 (0.73) | HDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL23745967 | 0.78 | HDAC1 (0.83) | HDAC1HDAC3HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021158869-A1 | COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES AND NERVE DAMAGE, AND METHODS FOR PREPARING COMPOUNDS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2021-08-12 | — | — | WO | disclosed |